Navigation Links
Notre Dame receives Gates grant for groundbreaking research in global heal
Date:6/3/2014

Marya Lieberman, associate professor of chemistry and biochemistry at the University of Notre Dame, has received a Grand Challenges Explorations grant, an initiative funded by the Bill & Melinda Gates Foundation. Lieberman will pursue an innovative global health and development research project, titled "Printed test cards for rapid field screening of human and animal medications."

Grand Challenges Explorations (GCE) funds individuals worldwide to explore ideas that can break the mold in how we solve persistent global health and development challenges. Lieberman's project is one of over 50 Grand Challenges Explorations Round 12 grants announced today by the Bill & Melinda Gates Foundation.

To receive funding, Marya Lieberman and other Grand Challenges Explorations Round 12 winners demonstrated in a two-page online application a bold idea in one of five critical global heath and development topic areas that included agriculture development, behavior change and looking into animal and human health. Applications for the next Round will be accepted starting September 2014.

Lieberman's team has designed an inexpensive paper test card that can detect low quality medications and apply economic pressure to companies that manufacture or distribute them. The World Health Organization estimates that 10 to 30 percent of human medications are of poor quality and an unknown percentage of animal medications is substandard or falsified. There is little chance that poor quality products will be caught by pharmaceutical buyers or drug regulatory agencies in developing countries, because it is so expensive to collect and test them, so low-quality products continue to harm both people and animals.

Lieberman's team will design a test card to monitor fifty types of human and animal medicines. Testing a sample of a medication is economical and accessible as there is no instrument to purchase, and the results of the test card can be read by eye or with a cell phone photograph. The test cards will enable people who buy large quantities of human or animal medications to steer clear of low-quality products and will help regulators to hold companies responsible for the quality of the medications they sell.

About Grand Challenges Explorations

Grand Challenges Explorations is a US$100 million initiative funded by the Bill & Melinda Gates Foundation. Launched in 2008, over 950 people in more than 55 countries have received Grand Challenges Explorations grants. The grant program is open to anyone from any discipline and from any organization. The initiative uses an agile, accelerated grant-making process with short two-page online applications and no preliminary data required. Initial grants of US$100,000 are awarded two times a year. Successful projects have the opportunity to receive a follow-on grant of up to US$1 million.

Lieberman is a member of Notre Dame's Eck Institute for Global Health which funded her initial exploratory research. She has partnered with the Academic Model Providing Access to Healthcare (AMPATH) which consists of Moi University School of Medicine and Moi Teaching and Referral Hospital in Eldoret, Kenya, and a consortium of North American academic centers. She has also partnered with Sidai which provides quality services to livestock keepers across Kenya. Her work is also supported by Notre Dame's Advanced Diagnostics and Therapeutics which provides diagnostics for the developing world. The PAD project is an evolving collaboration with Toni Barstis, professor of chemistry and physics at Saint Mary's College and with Notre Dame professors Holly Goodson, Patrick Flynn, Christopher Sweet, David Go, and Matthew Champion.


'/>"/>

Contact: Marissa Gebhard
gebhard.3@nd.edu
574-631-4465
University of Notre Dame
Source:Eurekalert

Related medicine news :

1. Second largest research award at Notre Dame fights malaria and dengue fever
2. Notre Dame FCU Sports Grumpy Cat Meme to Attract Gen Y Memberships
3. Notre Dame researchers offer new insights on cancer cell signaling
4. Notre Dame and Harper researchers developing novel method to test for HPV and oral cancers
5. New Notre Dame paper offers insights into how cancer cells avoid cell death
6. Notre Dame researchers scoring a win-win with novel set of concussion diagnostic tools
7. Notre Dame researchers paper examines the biology of tumor-derived microvesicles
8. Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
9. Miriam Hospital receives 8th consecutive award for quality care
10. Dr. Dobryakova of Kessler Foundation receives New Jersey Neuropsychological Society award
11. Richard Sylvester receives European Urology 2014 Platinum Award for Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the ... affiliation with Tennessee Counseling Association. This new relationship allows TherapySites to ... Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: